PerkinElmer has announced the acquisition of Geospiza, a developer of cloud-based software for use in genetic analysis and laboratory workflow management.
The company's clients include pharmaceutical and biotechnology firms, universities and researchers, with products including its GeneSifter Analysis Edition and Lab Edition offerings.
By purchasing the firm, PerkinElmer will be able to expand its presence in the next-generation DNA sequencing and analysis services market, thus allowing researchers to gain insight into the genetic origins of disease.
Dr Richard Begley, president of emerging technologies at PerkinElmer, said Geospiza is a leader in its sector and will help the company to offer an expanded range of nucleic acid testing products.
"Making sense of the unprecedented volumes of data generated by next-generation sequencing and other biological measurements is critical to improve the disease diagnosis process and drug discovery," he added.
Earlier this month, the company reported a 14 percent year-on-year revenue growth in its financial report for the first quarter of 2011.